Physician profile
Niraj V Patel
NPI 1326087610
$13,279.89
in general payments reported to CMS, 2019-2025
31 companies · $55.64 in 2025
The $55.64 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $275 · 2021: $615 · 2022: $730 · 2023: $11K · 2024: $337 · 2025: $55.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $11K · Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,500.00 |
| Food and Beverage | $869.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,583.33 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $552.42 | 2019-2022 | |
| Gynesonics, INC. | $207.35 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbott Laboratories | $156.87 | 2021 | |
| Pfizer INC. | $153.81 | 2019-2024 | |
| Myovant Sciences INC. | $134.81 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $131.38 | 2022-2025 | |
| Hologic Sales and Service, LLC | $121.25 | 2022-2024 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Therapeuticsmd, INC. | $103.95 | 2019-2022 | |
| Lupin INC. | $102.37 | 2019-2021 | |
| Evofem Biosciences, INC. | $98.58 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.50 | 2020-2024 | |
| Dysis Medical, INC. | $75.13 | 2020 | |
| Exeltis, USA INC. | $68.70 | 2021-2024 | Slynd |
| Roche Diagnostics Corporation | $65.35 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $65.10 | 2022 | |
| Organogenesis INC. | $65.00 | 2024 | |
| Coopersurgical, INC. | $63.86 | 2020-2023 | Mara Console, Summit Doppler |
| Myriad Women'S Health, INC. | $62.11 | 2023 | Myrisk |
| Astellas Pharma US INC | $60.67 | 2023-2024 | Veozah |
| Smith+Nephew, INC. | $48.08 | 2024-2025 | Pico 14 |
| Ethicon US, LLC | $39.40 | 2023 | Stratafix, Dermabond Prineo, Ethicon |
| Mimedx Group, INC. | $35.39 | 2024-2025 | |
| Allergan, INC. | $34.20 | 2019 | |
| Scynexis, INC. | $33.93 | 2022 | |
| Baxter Healthcare | $32.45 | 2023 | Tisseel |
| Shield Therapeutics INC | $22.90 | 2024 | |
| Organon LLC | $22.21 | 2023 | Nexplanon |
| Heron Therapeutics, INC. | $18.37 | 2023 | Zynrelef |
| Amag Pharmaceuticals, INC. | $15.89 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niraj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.